1750-43-2

Usage

Uses

Used in Pharmaceutical Research and Drug Development:
4-METHYLISOXAZOL-3-AMINE is utilized as a key intermediate in the synthesis of various organic compounds, particularly those with therapeutic potential. Its unique properties allow it to contribute to the development of new drugs and pharmaceutical agents.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 4-METHYLISOXAZOL-3-AMINE is employed as a building block for designing and creating novel molecules with potential therapeutic applications. Its structural attributes make it a versatile component in the creation of diverse chemical entities.
Used in Pharmacology:
4-METHYLISOXAZOL-3-AMINE has been studied for its potential biological activities and pharmacological effects, making it a subject of interest for researchers seeking to understand its role in biological systems and its potential as a therapeutic agent.
Overall, 4-METHYLISOXAZOL-3-AMINE's applications span across multiple scientific disciplines, highlighting its importance and versatility in research and development.

Upstream product

• 28786-90-5 2,3-dibromo-2-methylpropanenitrile 
• 127-07-1 N-hydroxyurea 
• 126-98-7 methacrylonitrile 

Downstream Products

• 1829-84-1 sulfamethoxazole 

Relevant academic research and scientific papers

N-(ISOXAZOL-3-YL)-ARYL-CARBOXYLIC ACID AMIDES AND USE THEREOF AS HERBICIDES

The invention relates to N-(isoxazol-3-yl)-aryl-carboxylic acid amides and use thereof as herbicides. In formula (I), A stands for N or C—Y. R, V, X, Y, and Z stand for groups such as hydrogen, halogen, and organic groups such as substituted alkyl.

QUINOLINE DERIVATIVES

The invention concerns quinoline derivatives of Formula I or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.

NAPHTHYRIDINE DERIVATIVES AS ANTI-CANCER AGENTS

The invention concerns naphthyridine derivatives of Formula (I): or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, G1, G2, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders or disease states associated with angiogenesis and/or vascular permeability.

QUINOLINE DERIVATIVES

The invention concerns quinoline derivatives of Formula (I): or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.